AG
RGNX icon

Advisor Group’s Regenxbio RGNX Stock Holding History

Advisor Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$47K Buy
1,158
+896
+342% +$35.4K ﹤0.01% 3463
2019
Q3 		$9K Sell
262
-1,300
-83% -$52.7K ﹤0.01% 4405
2019
Q2 		$82K Sell
1,562
-88
-5% -$4.39K ﹤0.01% 3006
2019
Q1 		$95K Buy
1,650
+1,477
+854% +$73.2K ﹤0.01% 2911
2018
Q4 		$7K Buy
173
+24
+16% +$1.41K ﹤0.01% 4380
2018
Q3 		$11K Buy
+149
New +$10.7K ﹤0.01% 4236

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Advisor Group's RGNX Position: Q4 2019 in Review

Advisor Group increased its Regenxbio (RGNX) stake by 342% in Q4 2019, buying an estimated $35.4K and bringing the position to 1,158 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

Advisor Group first reported a position in RGNX in Q3 2018 and has held it in 6 quarters since. The position peaked at $95K in Q1 2019. 187 funds tracked by Wall St. Rank hold RGNX as of Q4 2019.

  • Advisor Group held 1,158 shares of Regenxbio worth $47K as of Q4 2019.
  • Advisor Group bought 896 Regenxbio shares in Q4 2019, an estimated $35.4K.
  • Regenxbio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3463 holding.
  • Advisor Group first reported a position in Regenxbio in Q3 2018 and has held it in 6 quarters since.
  • Advisor Group's Regenxbio position peaked at $95K in Q1 2019.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.